AI assistant
EXELIXIS, INC. — Director's Dealing 2021
Jan 7, 2021
30561_dirs_2021-01-06_2a5c6502-345e-44c5-8416-cb52eb957586.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2021-01-04
Reporting Person: Hessekiel Jeffrey (EVP and General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-17 | Common Stock | G | 2500 | — | Disposed | 491754 | Direct |
| 2021-01-04 | Common Stock | M | 30000 | $7.27 | Acquired | 521754 | Direct |
| 2021-01-04 | Common Stock | M | 20000 | $1.90 | Acquired | 541754 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-01-04 | Option (right to buy) | $7.27 | M | 30000 | Disposed | 2021-02-09 | Common Stock (30000.0) | Direct |
| 2021-01-04 | Option (right to buy) | $1.9 | M | 20000 | Disposed | 2022-02-04 | Common Stock (20000.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 999 | Indirect |
Footnotes
F1: Includes 108,613 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
F2: Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of January 4, 2021.
F3: The option, representing the right to purchase a total of 230,000 shares of Exelixis, Inc. common stock, became fully exercisable on February 10, 2018.
F4: The option, representing the right to purchase a total of 200,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016.